Find information on thousands of medical conditions and prescription drugs.

Ticarcillin

Ticarcillin, also known as Timentin, is a Beta-lactam antibiotic similar to penicillin. It is often used as an injectable antibiotic for the treatment of gram negative bacteria, and is especially effective against Pseudomonas aeruginosa. Its antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis when the bacteria tries to divide, causing death. It will not treat viruses, including the flu. Because it is similar in structure to penicillin, it should not be used by anyone with allergies to any penicillin-related antibiotic. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Many bacteria have developed a resistance to this antibiotic by producing beta-lactamase, which inactivates it. Therefore, all modern ticarcillin includes clavulanic acid, an inbibitor of these enzymes.

In molecular biology, ticarcillin is used to as an alternative to ampicillin to test the uptake of marker genes into bacteria. It prevents the appearance of satellite colonies that occur when ampicillin breaks down in the media. It is also used in plant molecular biology to kill agrobacterium, which is used to deliver genes to plant cells.

Chemically, ticarcillin is C15H16N2O6S2 (CAS number 34787-01-4). It is provided as a white or pale yellow powder. It is highly soluble in water, but should only be dissolved immediately prior to use to prevent degradation.

Read more at Wikipedia.org


[List your site here Free!]


Clinical characteristics and risk factors of mortality among severe burn patients with isolates of vancomycin-resistant enterococci
From CHEST, 10/1/05 by Heung J. Woo

PURPOSE: Vancomycin-resistant enterococci (VRE) are multi-drug resistant organisms that have emerged as important nosocomial pathogens in recent years. VRE emergence has been blamed mainly on the increased and inappropriate use of antibiotics, in particular, the cephalosporins and the glycopeptide, vancomycin. Burn patients are highly vulnerable to acquiring VRE infection. This study was focused on the clinical characteristics and risk factors of mortality among severe burn patients with VRE isolation during recent 4 years.

METHODS: 104 cases (M:F=69:35) that had VRE isolation from January 1, 2000 to December, 2003, were reviewed. We analyzed clinical characteristics and the risk factors that contribute to death by using univariate and multivariate analyses, retrospectively.

RESULTS: Mean percent total body surface area (%TBSA) of survivors (n=80) and non-survivors (n=24) were 41.64 [+ or -] 20.68% and 58.08 [+ or -] 22.64% (p=0.003). Total 144 strains of VRE were isolated from 104 patients. Most of VRE colonization or infection were caused by Enterococcus faecium (82.6%) and E. casseliflavus (14.6%). There were no significant difference in VRE species distribution between survivors and non-survivors (p> 0.05). The risk factors for mortality were %TBSA burn, APACHE II scores, mechanical ventilation, nasogastric tube, previous use of cefepime and ticarcillin/clavulanate, rectal VRE colonization and initial VRE bacteremia in univariate analysis. However, independent risk factor of death were APACHE II score, mechanical ventilation and initial VRE bacteremia in multivariate analyses.

CONCLUSION: Severe burn patients with VRE isolation should be reassessed carefully, especially in those who had high APACHE II scores at ICU admission, mechanical ventilation and initial VRE bacteremia.

CLINICAL IMPLICATIONS: More strict infection control and efforts to eradicate VRE may be needed among severe burn patients with VRE isolation.

DISCLOSURE: Heung Woo, None.

Heung J. Woo MD * Cheol H. Kim MD Jin K. Kim MD Young I. Park MD In G. Hyun MD Young M. Ahn MD Department of Internal Medicine, Hallym University College of Medicine, Seoul, South Korea

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Ticarcillin
Home Contact Resources Exchange Links ebay